Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01241708
Title Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma ((Mel/MelVel))
Acronym (Mel/MelVel)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hackensack University Medical Center
Age Groups: adult
Covered Countries USA

No variant requirements are available.